MacroGenics (MGNX) PT Raised to $21 at Stifel
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.58 +10.90%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Stifel analyst Stephen Willey raised the price target on MacroGenics (NASDAQ: MGNX) to $21.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald
- MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
